CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
Open platformOpen platform

Ginkgo Bioworks Q3 2026 net loss narrows 49% year over year to $40.98 million

By Public Technologies
  • Ginkgo Bioworks’ third-quarter 2026 net loss from continuing operations narrowed 44% year over year to $40.98 million.
  • Revenue fell 6% year over year to $27.71 million; cash, cash equivalents and marketable securities totaled $285 million at September 30.
  • The company signed its first autonomous lab sale to top-tier pharmaceutical company Novo for its new Waltham, Massachusetts, research site.
  • An ARPA-H GIVE subcontract worth up to $17.5 million will deploy its autonomous lab systems in RNA-medicine manufacturing.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ginkgo Bioworks Holdings Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202611051605BIZWIRE_USPR_____20261105_BW540481) on November 05, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk